Target Name: FAM166C
NCBI ID: G339778
Other Name(s): FAM166C variant 1 | Family with sequence similarity 166 member C, transcript variant 1 | Protein FAM166C (isoform 1) | Protein FAM166C | Family with sequence similarity 166 member C | F166C_HUMAN | UPF0573 protein C2orf70 | family with sequence similarity 166 member C | C2orf70

FAM166C: A Potential Drug Target Or Biomarker

FAM166C (FAM166C variant 1) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The FAM166C gene is located on chromosome 16 and encodes for a protein known as FAM166C, which is a key regulator of cell growth and differentiation. The FAM166C gene has four splice variants, two of which have been reported to cause a genetic disorder known as polycystic ovary syndrome (PCOS).

While the exact function of the FAM166C gene is not yet fully understood, research has shown that it plays a role in the development and maintenance of various diseases. For example, studies have found that individuals with PCOS have reduced levels of FAM166C in their ovaries, which could contribute to the development of the disorder. Additionally, there is evidence to suggest that FAM166C may be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

FAM166C has also been shown to be involved in cancer development. For example, studies have found that FAM166C is highly expressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that FAM166C may be a useful target for cancer therapies that target these diseases.

In addition to its potential as a drug target or biomarker, FAM166C has also been shown to have potential as a diagnostic tool. Studies have found that FAM166C is expressed in a variety of tissues and cells, including cancer cells, fetal tissues, and brain cells. This makes it a potential candidate for use as a diagnostic biomarker for various diseases, including cancer.

Overall, the FAM166C gene has a significant potential as a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its function and to develop effective therapies and diagnostic tools based on it.

Protein Name: Family With Sequence Similarity 166 Member C

More Common Targets

FAM167A | FAM167A-AS1 | FAM167B | FAM168A | FAM168B | FAM169A | FAM169BP | FAM170A | FAM170B | FAM170B-AS1 | FAM171A1 | FAM171A2 | FAM171B | FAM172A | FAM172BP | FAM174A | FAM174B | FAM174C | FAM177A1 | FAM177B | FAM178B | FAM180A | FAM180B | FAM181A | FAM181B | FAM182A | FAM182B | FAM183A | FAM183BP | FAM184A | FAM184B | FAM185A | FAM185BP | FAM186A | FAM186B | FAM187B | FAM187B2P | FAM193A | FAM193B | FAM197Y2 | FAM199X | FAM200A | FAM200B | FAM200C | FAM201A | FAM204A | FAM205A | FAM205BP | FAM207BP | FAM209A | FAM209B | FAM20A | FAM20B | FAM20C | FAM210A | FAM210B | FAM215A | FAM216A | FAM216B | FAM217A | FAM217B | FAM218A | FAM219A | FAM219B | FAM21B | FAM21EP | FAM220A | FAM220BP | FAM221A | FAM221B | FAM222A | FAM222A-AS1 | FAM222B | FAM223A | FAM223B | FAM224A | FAM224B | FAM225A | FAM225B | FAM226B | FAM227A | FAM227B | FAM228A | FAM228B | FAM229A | FAM229B | FAM230B | FAM230F | FAM230H | FAM230I | FAM230J | FAM234A | FAM234B | FAM237A | FAM237B | FAM238B | FAM238C | FAM239B | FAM240C | FAM241A